A. R. Ahmed et al., Ccyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses, J. Am. Acad. Dermatol., Dec. 1984, pp. 1115-1126. |
K. D. Bagshawe, Third Gordon Hamilton-Fairley Memorial Lecture, "Tumour markers-Where do we go from here?", Br. J. Cancer, 48, pp. 167-175 (1983). |
I. Hellstrom et al., "Monoclonal Mouse Antibodies Raised Against Human Lung Carcinoma", Cancer Research, 46, pp. 3917-3923 (Aug. 1986). |
G. W. Philpott et al., "Affinity Cytotoxicity of Tumor Cells With Antibody-Glucose Oxidase Conjugates, Peroxidase, and Arspehnamine", Cancer Research, pp. 2159-2164 (Sep. 1974). |
I. Hellstrom et al., "Monoclonal Antibodies to Two Determinants of Melanoma-Antigen p97 Act Synergistically in Complement-Dependent Cytotoxicity", The Journal of Immunology, 127(1). pp. 157-160 (Jul. 1981). |
V. J. Stella et al., "Prodrugs: A Chemical Approach to Targeted Drug Delivery", Directed Drug Delivery, pp. 247-267 (1985). |
T. Nishiyama et al., "Antineoplastic Effects in Rats of 5-Fluorocytosine in Combination with Cytosine Deaminase Capsules", Cancer Research, 45, pp. 1753-1761 (Apr., 1985). |
D. E. V. Wilman, "Prodrugs in Cancer Chemotherapy", Biochemical Society Transactions, 14, pp. 375-382, (615th Meeting, Belfast 1986). |
P. J. O'Dwyer et al., The New England Journal of Medicine, 312, pp. 692-700 (Mar. 14, 1985). |
A. P. Albino et al., "Heterogeneity in Surface Antigen and Glycoprotein Expression of Cell Lines Derived from Different Melanoma Metastases of the Same Patient", J. Exp. Med., 154, pp. 1764-1778 (Dec. 1981). |
R. Amon et al., "In Vitro and In Vivo Efficacy of Conjugates of Daunomycin with Anti-Tumor Antibodies", Immunological Rev., 62, pp. 5-27 (1982). |
K. D. Bagshawe, "Antibody Directed Enzymes Revive Anti-Cancer Prodrugs Concept", Br. J. Cancer, 56, pp. 531-532 (Nov. 1987). |
K. D. Bagshawe, "A Novel Approach to Prodrug Activation Using a Monoclonal Antibody Conjugated to Carboxypeptidase G2", from the Third International Conference on Monoclonal Antibody Immunoconjugates for Cancer, Abstract #43, p. 70 (San Diego, Feb. 4-6, 1988). |
R. W. Baldwin et al., "Design and Therapeutic Evaluation of Monoclonal Antibody 791T/36-Methotrexate Conjugates", Monoclonal Antibodies and Cancer Therapy, pp. 215-231 (1985). |
R. W. Baldwin et al., Monoclonal Antibodies in Cancer Treatment, Lancet, pp. 503-605 (Mar. 15, 1986). |
R. W. Baldwin et al., "Monoclonal Antibody Drug Conjugates for Cancer Therapy" Monoclonal Antibodies in Cancer: Advances in Diagnosis and Treatment, pp. 215-257 (1986). |
J. P. Brown et al., "Structural Characterization of Human Melanoma-Associated Antigen p97 with Monoclonal Antibodies", J. Immunology, 127(2) pp. 539-546 (Aug., 1981). |
E. A. Clark et al., "Role of the Bp35 Cell Surface Polypeptide in Human B-Cell Activation", Proc.Natl. Acad.Sci., 82, pp. 1766-1770 (Mar. 1985). |
S. T. Crook et al., (eds) Anthracyclines: Current Status and New Developments, Academic Press, cover pages and table of contents, (New York, 1980). |
R. A. DeWeger et al., "Eradication of Murine Lymphoma and Melanoma Cells by Chlorambucil-Antibody Complexes", Immunological Rev., 62, pp. 29-45 (1982). |
M. J. Embelton et al., "Antibody Targeting of Anti-Cancer Agents", Monoclonal Antibodies for Cancer Detection and Therapy, pp. 321-322 (1985). |
M. J. Embelton et al., "Targeting of Anti-Cancer Therapeutic Agents by Monoclonal Antibodies", Biochemical Society Transactions, 14, pp. 393-395 (615th Meeting, Belfast 1986). |
N. Endo et al., "In Vitro Cycotoxicity of a Human Serum Albumin-Medicated Conjugate of Methotrexate with Anti-MM46 Monoclonal Antibody", Cancer Research, 47, pp.1076-1080 (Feb. 15, 1987). |
I. Hellstrom et al., "Antitumor Effects of L6, an IgG2a Antibody that Reacts with Most Human Carcinomas", Pro.Natl.Acad.Sci.U.S.A., 83, pp. 7059-7063 (Sep. 1986). |
I. Hellstrom et al., "Antibodies for Drug Delivery", Controlled Drug Delivery, (2nd Ed.) pp. 638-642 (1987). |
P. L. Ipata et al., "Baker's Yeast Cytosine Deaminase. Some Enzymic Properties and Allosteric Inhibition by Nucleosides and Nucleotides", Biochemistry, 10(23) pp. 4270-4276 (1971). |
T. Katsuragi et al., "Affinity Chromatography of Cytosine Deaminase from Excherichia coli with Immobilized Pyrimidine Compounds", Agric. Biol. Chem., 50(7), pp. 1713-1719 (1986). |
J.M. Lambert et al., "Purified Immunotoxins That Are Reactive with Human Lymphoid Cells", J. Biol. Chemistry, 260(22), pp. 12035-12041 (1985). |
R. W. Baldwin et al. (eds), pp. 53-64, Academic Press (1985). |
R. B. McComb et al. (eds), Alkaline Phosphatase, Plenum Press, Chapters 4, 5, 6 and 11 (New York 1979). |
R. G. Melton et al., "In Vivo Localization of Carboxypeptidase G2-Antibody Conjugates in Human Colon Carcinoma Xenografts", from the Third International Conference on Monoclonal Antibody Immunoconjugates for Cancer, Abstract #83, p. 110 (San Diego, Feb. 4-6, 1988). |
S. Monfardini et al. (eds), Manual of Cancer Chemotherapy, Third Ed., UICC Technical Support Series, 56, Table of Contents, pp. 1-230 (Geneva 1981). |
F. L. Moolten et al., "Antibodies Conjugated to Potent Cytotoxins as Specific Antitumor Agents", Immunological Rev., pp. 47-73 (1982). |
C. W. Parker et al., "Enzymatic Activation and Trapping of Luminol-Substituted Peptides and Proteins. A Possible Means of Amplifying the Cytotoxicity of Anti-Tumor Antibodies", pro. Nat.Acad.Sci. USA, 72(1), pp. 338-342 (1975). |
G. W. Philpott et al., "Selective Iodination and Cytotoxicity of Tumor Cells with an Antibody-Enzyme Conjugate", Surgery, 74(1), pp. 51-58 (1975). |
G. W. Philpott et al., "Selective Cytotoxicity of Hapten-Substituted Cells with an Antibody--Enzyme Conjugate", The Journal of Immunology, 111(3), pp. 921-929 (1973). |
M. J. Robins et al., "Nucleic Acid Related Compounds. 16. Direct Fluorination of Uracil Nucleotides Using Trifluoromethyl Hypofluorite", Can. J. Chem., 53, pp. 1302-1306 (1975). |
G. F. Rowland et al., "Drug Localisation and Growth Inhibition Studies of Vindesine-Monoclonal Anti-CEA Conjugates in a Human Tumour Xenograft", Cancer Immunol Immunother. 21, pp. 183-187 (1986). |
F. Searle et al., "Antibody Carboxypeptidase G2 Conjugates as Anti-Tumor Agent", Tumor Biology, 6(4), p. 355 (1985). |
F. Searle et al., "Carboxypeptidase G2 Conjugates with Localizing Anti-Tumour Antibodies: Potential Therapeutic Agents", Tumor Biology, 7(4), p. 320 (1986). |
F. Searle et al., "The Potential of Carboxypeptidase G2 Antibody Conjugates as Anti-Tumour Agents. I. Preparation of Antihuman Chorionic Gonadotrophin-Carobyxpeptidase G2 and Cytotoxicity Against JAR Choriocarcinoma Cells In Vitro", Br. J. Cancer, 53, pp. 377-384 (1986). |
W. T. Shearer et al., "Cytotoxicity with Antibody-Glucose Oxidase Conjugates Specific for a Human Colonic Cancer and Carcinoembryonic Antigen", Int. J. Cancer, 14, pp. 539-547 (1974). |
V. J. Stella et al., "Prodrugs Do They Have Advantages in Clinical Practice?", Drugs, 29, pp. 455-473 (1985). |
W. A. Thomas, "Prodrugs", Biochemical Society Transactions, 14, pp. 383-387, (615th Meeting, Belfast 1986). |
P. E. Thorpe et al., "The Preparation and Cytotoxic Properties of Antibody-Toxin Conjugates", Immunological Rev., 62, pp. 119-158 (1982). |
P. E. Thorpe, "Antibody Carriers of Cytotoxic Agents in Cancer Therapy: A Review", Monoclonal Antibodies '84 Biological and Clinical Applications, pp. 475-506 (1985). |
E. S. Vitetta et al., "Redesigning Nature's Posions to Create Anti-Tumor Reagents", Science, 238, pp. 1098-1104 (1987). |
M. Y. Yeh et al., "Cell Surface Antigens of Human Melanoma Identified by Monoclonal Antibody", Proc.Natl.Acad.Sci (USA, 76(6), pp. 2927-2931 (1979). |
M. Y. Yeh et al., "Clonal Variation in Expression of a Human Melanoma Antigen Defined by a Monoclonal Antibody", J. Immunol. 126(4), pp. 1312-1317 (1981). |
P. J. Fraker et al., "Protein and Cell Membrane Iodinations with a Sparingly Soluble Chloroamide 1,3,4,6-Tetrachloro-31,6a-Diphenylglycolunil", Biochem. Biophysical Research Comm., 80(4), pp. 849-857 (Feb. 1978). |
J. P. Mach et al., "Improvement of Colon Carcinoma Imaging: From Polyclonal Anti-CEA Antibodies and Static Photoscanning to Monoclonal Fab Fragments and ECT", Monoclonal Antibodies for Cancer Detection and Therapy, pp. 53-64 (1985). |
K. Ohkawa et al. "Selective in Vitro and In Vivo Growth Inhibition Against Human Yok Sac Tumor Cell Lines by Purified Antibody Against Human .alpha.-Fetoprotein Conjugated with Mitomycin C via Human Serum Albumin", Cancer Immunol. Immunother, 23, pp. 81-86 (1986). |